C反应蛋白与双相障碍 euthymic 患者认知表现相关
本研究在222例 euthymic 双相障碍患者和52名健康对照中测量C反应蛋白(CRP),比较CRP≥5 mg/L与<5 mg/L患者的认知表现。结果发现高CRP患者在执行功能、MATRICS处理速度和推理解决问题上表现更差,且CRP是代理认知下降的显著正向预测因子,提示炎症升高与双相障碍缓解期广泛认知功能障碍相关。
要点
- CRP≥5 mg/L的双相障碍患者执行功能、处理速度和推理解决问题表现更差。
- CRP是代理认知下降(病前与当前IQ差值)的显著正向预测因子。
- 结果提示高CRP可能标识可从抗炎治疗中获益的认知障碍亚组。
核心结论
- 升高的CRP与情感缓解期双相障碍患者的广泛认知功能障碍相关。
- CRP可能是预测双相障碍认知缺陷的生物标志物。
研究设计与样本
- 在222例 euthymic 双相障碍患者和52名健康对照中测量CRP。
- 在患者样本内用协方差多变量分析(MANCOVA)比较CRP≥5 mg/L与<5 mg/L者的认知表现。
- 用代理认知下降指标(病前与当前IQ估计差值)进行逻辑回归分析。
- 样本中约80%为双相I型,其余为双相II型,42.6%有精神病性症状史。
主要发现
- CRP对广泛认知测验表现有统计学显著效应。
- CRP≥5 mg/L者在执行功能、MATRICS处理速度及MATRICS推理与问题解决多项指标上表现更差。
- CRP是代理认知下降的显著正向预测因子。
关键数值与推荐
- 高CRP定义为≥5 mg/L,其余受试者CRP<5 mg/L。
临床怎么用
- 对双相障碍缓解期患者可考虑检测CRP以识别认知障碍风险较高的亚组。
- 高CRP患者可能适合接受降低炎症的干预,但需进一步研究验证。
局限性
- 原文未报告研究设计类型、样本来源、随访时长及混杂因素控制细节。
- 代理认知下降基于病前与当前IQ估计差值,非纵向认知评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Data support the notion that 40-60% of patients with bipolar disorder (BD) have neurocognitive deficits. It is increasingly accepted that functioning in BD is negatively impacted by these deficits, yet they have not been a successful target for treatment. The biomarkers that predict cognitive deficits in BD are largely unknown, however recent evidence suggests that inflammation may be associated with poorer cognitive outcomes in BD. We measured C-reactive protein (CRP), a marker of systemic inflammation and risk of inflammatory disease, in 222 euthymic BD patients and 52 healthy controls. Within the patient sample, using multivariate analyses of covariance (MANCOVA) we compared cognitive performance of those with high CRP (≥5 mg/L) versus the remaining subjects (<5 mg/L) on a battery of cognitive tests. We evaluated relationships with several other relevant clinical features. We also examined the role of CRP in cognitive decline using a proxy cognitive decline metric, defined as the difference between premorbid and current IQ estimates, in a logistic regression analysis. Approximately 80% of our sample were BD-I, and the remainder were BD-II and 42.6% of our sample had a history of psychosis. We found a statistically significant effect of CRP on cognitive performance on a broad range of tests; participants with CRP ≥ 5 mg/L had worse performance on several measures of executive functioning, MATRICS processing speed and MATRICS reasoning and problem solving relative to those with lower CRP. We also identified CRP as a significant positive predictor of proxy cognitive decline. Our results indicate that elevated CRP is associated with a broad cognitive dysfunction in affectively remitted BD patients. These results may point to a subgroup of patients who might benefit from treatments to reduce inflammation.
引用
- Millett CE, Perez-Rodriguez M, Shanahan M, et al. C-reactive protein is associated with cognitive performance in a large cohort of euthymic patients with bipolar disorder. Mol Psychiatry. 2019. PMID: 31740754. doi:10.1038/s41380-019-0591-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。